NovelStem International Corp.
NSTM· OTC
Filed Aug 6, 2025 · 10-Q · 37 days after period end · 0001493152-25-011661
| Metric | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 |
|---|---|---|---|---|
| Net Income | $2.75M | -$302.63K | -$2.87M | -$169.34K |
| EPS Diluted | $0.06 | -$0.01 | -$0.06 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
NovelStem International Corp. · CIK 912544 · Engraved from SEC EDGAR
ended Jun 30, 2025 · filed Aug 6, 2025 · 37 d after period end